Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: arzoxifene hydrochloride|DRUG: tamoxifen citrate
Sponsor: University of Kansas Medical Center
Collaborators: National Cancer Institute (NCI)